CAMBRIA-1 & CAMBRIA-2 phase III trials: camizestrant versus standard endocrine therapy in ER+/HER2- early breast cancer
CAMBRIA-1 和 CAMBRIA-2 III 期试验：卡美司群与标准内分泌疗法治疗 ER+/HER2- 早期乳腺癌
期刊:Future Oncology
影响因子:2.6
doi:10.1080/14796694.2025.2459548
Hamilton, Erika P; Loibl, Sibylle; Bachelot, Thomas; Gnant, Michael; Niikura, Naoki; Park, Yeon Hee; Tolaney, Sara M; Pistilli, Barbara; Rastogi, Priya; Saini, Kamal S; Gioni, Ioanna; Johnston, Simon; Nunes, Raquel; Quintana, Angela; Stuart, Mary; Syta, Emilia; Walding, Andrew; Klinowska, Teresa; Mayer, Ingrid A
